Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 84

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 84
---
 $
    3,603

    $
    83,990,437

    $
    (70,532,323
    )
     
    $
    13,461,717

    Issuance of    Common Stock upon exercise of stock options

    13,473

    1

    2,443

    —

    2,444

    Issuance of    Common Stock upon equity subscription

    1,785,718

    178

    2,499,827

    —

    2,500,005

    Issuance of    Common Stock

    4,160,000

    416

    2,452,249

    —

    2,452,665

    Issuance of warrants

    —

    —

    4,465,589

    —

    4,465,589

    Exercise of pre-funded warrants

    2,557,000

    256

    —

    —

    256

    Issuance cost of common stock

    —

    —

    (226,201
    )

    —

    (226,201
    )

    Issuance costs of common stock warrants

    —

    —

    (411,844
    )

    —

    (411,844
    )

    Stock-based compensation

    —

    —

    1,009,011

    —

    1,009,011

    Net loss

    —

    —

    —

    (30,023,814
    )

    (30,023,814
    )

    Balance, December 31, 2024

    44,541,295

    $
    4,454

    $
    93,781,511

    $
    (100,556,137
    )
     
    $
    (6,770,172
    )

The accompanying notes are an integral part of these financial statements. 

101

HCW Biologics Inc.

Statements of Cash Flows 

    Years Ended December 31,

    2023

    2024

    Cash flows from operating activities:

    Net loss
     
    $
    (24,994,277
    )
     
    $
    (30,023,814
    )

    Adjustments to reconcile net loss to net cash used in operating activities:

    Depreciation and amortization